J Lipid Atheroscler.
2025 May;14(2):188-189. 10.12997/jla.2025.14.2.188.
HDL-C and Hematologic Malignancies: A Commentary on Cohort Study
- Affiliations
-
- 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Korea
- KMID: 2568351
- DOI: http://doi.org/10.12997/jla.2025.14.2.188
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Discrepant Effect of High-Density Lipoprotein Cholesterol on the Hematologic Malignancy Risk: A Nationwide Cohort Study
- Risk of Hematologic Malignancies in Patients with Inflammatory Bowel Disease: A Meta-Analysis of Cohort Studies
- Incidence and Types of Constitutional Chromosomal Abnormalities in Patients with Hematologic Malignancies
- Illness Experience of Adolescents with Hematologic Malignancies
- Extracorporeal Life Support in Patients with Hematologic Malignancies: A Single Center Experience
